Health Score

0 Poor

Metadata coverage

Abstract

ORCID

References

License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder

Award / grant

Affiliation & institutional identifiers

Affiliation

ROR ID

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

Deposit reference lists for 287 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

High impact287 DOIs

Add license metadata to 287 records

License metadata tells indexers and readers how each article may be reused.

High impact287 DOIs

Attach ORCID iDs across 281 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact281 DOIs

DOIs for this ISSN

Showing the top 5 of 285 DOIs, ordered by correction priority.

#	Title	Missing	Priority	Citations
1	Epidemiological analysis primary open-angle glaucoma inciden… (10.32364/2311-7729-2022-22-1-3-10)	References ORCID License	110.78	29
2	State-of-the-art cataract surgery. Nuances and solutions (10.32364/2311-7729-2020-20-3-142-147)	Abstract References ORCID License	90.31	7
3	Age-related cataract: prevention and treatment (10.21689/2311-7729-2018-18-4-194-198)	Abstract References ORCID License	84.51	6
4	Diagnostic criteria for asthenic accommodative asthenopia in… (10.32364/2311-7729-2020-20-4-169-174)	References ORCID License	80.94	11
5	Dynamics of epidemiological indicators of glaucoma in the Re… (10.21689/2311-7729-2018-18-4-163-167)	Abstract References ORCID License	77.82	5
6	Influence of prostaglandin analogues on intraocular pressure… (10.32364/2311-7729-2022-22-2-103-107)	References ORCID License	75.00	9
7	Dry eye disease in keratoconus: etiology and medical treatme… (10.32364/2311-7729-2022-22-2-122-126)	References ORCID License	75.00	9
8	The prevalence of conjunctivitis in patients with novel coro… (10.32364/2311-7729-2020-20-2-92-96)	Abstract References License	71.57	8
9	Future of artificial intelligence for the diagnosis and trea… (10.32364/2311-7729-2022-22-1-36-43)	References ORCID License	67.73	7
10	The first experience with brolucizumab for neovascular age-r… (10.32364/2311-7729-2022-22-2-108-115)	References ORCID License	67.73	7
11	Epidemiology of hereditary eye disease in the populations of… (10.32364/2311-7729-2022-22-2-69-79)	References ORCID License	67.73	7
12	Ocular aberrations in keratoconus (10.32364/2311-7729-2022-22-3-168-174)	References ORCID License	67.73	7
13	Making a diagnosis of glaucoma at the present time (10.32364/2311-7729-2023-23-1-47-53)	References ORCID License	67.73	7
14	Medical treatment for dry eye in patients with keratoconus a… (10.32364/2311-7729-2020-20-2-67-71)	Abstract References License	63.38	6
15	Prevalence of dry eye disease in Russia (10.32364/2311-7729-2021-21-2-96-102)	References ORCID License	63.38	6
16	Realization of a cascade treatment algorithm for glaucoma in… (10.32364/2311-7729-2021-21-3-123-128)	References ORCID License	63.38	6
17	State-of-the-art etiology and pathogenesis of dry eye (10.32364/2311-7729-2020-20-3-128-132)	Abstract References ORCID License	60.21	3
18	Rhegmatogenous retinal detachment: current treatment approac… (10.32364/2311-7729-2020-20-2-72-78)	Abstract References License	58.36	5
19	IOP-lowering therapy and ocular surface in glaucoma. Part 1.… (10.32364/2311-7729-2020-20-2-79-84)	Abstract References License	58.36	5
20	Comparative quantitative assessment of the placement and int… (10.32364/2311-7729-2021-21-2-58-62)	References ORCID License	58.36	5
21	Surgical repair of conjunctival defects: perspectives and li… (10.32364/2311-7729-2022-22-2-137-144)	References ORCID License	58.36	5
22	The efficacy of sinustrabeculectomy in the modern clinical p… (10.32364/2311-7729-2023-23-1-21-26)	References ORCID License	58.36	5
23	Microperimetry as a tool to assess retinal functional parame… (10.32364/2311-7729-2020-20-2-51-55)	Abstract References License	52.42	4
24	Ocular surface treatment in dry eye patients before corneal… (10.32364/2311-7729-2020-20-4-180-186)	References ORCID License	52.42	4
25	Thermography in posterior scleritis (10.32364/2311-7729-2020-20-4-204-208)	References ORCID License	52.42	4
26	Analysis of central retinal microcirculation in glaucoma aft… (10.32364/2311-7729-2021-21-1-3-8)	References ORCID License	52.42	4
27	Early diagnosis and the effect of treatment compliance on th… (10.32364/2311-7729-2021-21-1-34-39)	References ORCID License	52.42	4
28	Ophthalmological monitoring in patients with hypertension an… (10.32364/2311-7729-2021-21-2-51-57)	References ORCID License	52.42	4
29	Glaucoma progression during the COVID-19 pandemics (10.32364/2311-7729-2021-21-3-147-152)	References ORCID License	52.42	4
30	Antibiotic prophylaxis of acute postoperative endophthalmiti… (10.32364/2311-7729-2021-21-4-220-226)	References ORCID License	52.42	4
31	Efficiency of topical application of regenerants and reparen… (10.32364/2311-7729-2021-21-4-253-257)	References ORCID License	52.42	4
32	Genetic testing of ocular manifestations of proliferative sy… (10.32364/2311-7729-2022-22-1-16-22)	References ORCID License	52.42	4
33	Role of neuroinflammation in the pathogenesis of glaucomatou… (10.32364/2311-7729-2022-22-2-116-121)	References ORCID License	52.42	4
34	Characteristics of visual functions and their correlation wi… (10.32364/2311-7729-2022-22-4-216-223)	References ORCID License	52.42	4
35	Glaucoma "landscape" in Russia, CIS and Eastern European cou… (10.32364/2311-7729-2023-23-2-73-79)	References ORCID License	52.42	4
36	Modern possibilities of sodium hyaluronate in tear substitut… (10.21689/2311-7729-2018-18-4-179-185)	Abstract References ORCID License	47.71	2
37	New possibilities of using methylaethylpiridinolum in ophth… (10.21689/2311-7729-2018-18-4-190-192)	Abstract References ORCID License	47.71	2
38	Circumscribed choroidal hemangioma: clinical course and trea… (10.32364/2311-7729-2020-20-2-56-62)	Abstract References ORCID License	47.71	2
39	Maintenance of visual functions in patients with a scheduled… (10.32364/2311-7729-2020-20-3-117-121)	Abstract References ORCID License	47.71	2
40	IOP-lowering therapy and ocular surface in glaucoma. Part 2.… (10.32364/2311-7729-2020-20-3-133-141)	Abstract References ORCID License	47.71	2
41	Diagnostics of glaucoma before clinical manifestations (10.32364/2311-7729-2020-20-3-152-158)	Abstract References ORCID License	47.71	2
42	Current treatment modalities for dry eye disease (10.32364/2311-7729-2021-21-1-18-23)	References ORCID License	45.15	3
43	Activation of uveolymphatic outflow pathway after non-penetr… (10.32364/2311-7729-2021-21-2-108-115)	References ORCID License	45.15	3
44	Impact of glaucoma and glaucoma surgery on quality of life (10.32364/2311-7729-2022-22-1-44-50)	References ORCID License	45.15	3
45	Blepharoplasty: historical aspects, terminology, and modern… (10.32364/2311-7729-2022-22-2-127-131)	References ORCID License	45.15	3
46	Development of a Russian version of the Minnesota low vision… (10.32364/2311-7729-2022-22-3-150-155)	References ORCID License	45.15	3
47	Characteristics of glaucoma therapy with prostaglandin analo… (10.32364/2311-7729-2022-22-3-175-180)	References ORCID License	45.15	3
48	Anti-VEGF therapy for diabetic macular edema: up-to-date app… (10.32364/2311-7729-2022-22-3-181-186)	References ORCID License	45.15	3
49	The results of using micropulse cyclophotocoagulation for th… (10.32364/2311-7729-2022-22-4-204-209)	References ORCID License	45.15	3
50	Selective micropulse individual retinal therapy in the navig… (10.32364/2311-7729-2023-23-3-1)	References ORCID License	45.15	3